Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach | PLOS ONE
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer - ESMO Open
![Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial - Lung Cancer Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f005b14a-7363-40b8-9555-04b10fc3bf44/gr1_lrg.jpg)
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial - Lung Cancer
![Un paziente con tumore del polmone su quattro è malnutrito con conseguenze su prognosi e risposta alle terapie" una review Gemelli approfondisce il rapporto tra Nutrizione e Oncologia - CEMAD - Centro Un paziente con tumore del polmone su quattro è malnutrito con conseguenze su prognosi e risposta alle terapie" una review Gemelli approfondisce il rapporto tra Nutrizione e Oncologia - CEMAD - Centro](https://www.cemadgemelli.it/wp-content/uploads/2021/01/news-salute-1280x660-1.jpg)
Un paziente con tumore del polmone su quattro è malnutrito con conseguenze su prognosi e risposta alle terapie" una review Gemelli approfondisce il rapporto tra Nutrizione e Oncologia - CEMAD - Centro
![Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis - Clinical Nutrition Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis - Clinical Nutrition](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f36484a5-f328-4f9e-a7ab-6ae1a5b63813/gr1_lrg.jpg)
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis - Clinical Nutrition
![Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy - Banna - 2022 - Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy - Banna - 2022 -](https://onlinelibrary.wiley.com/cms/asset/609783f9-35a7-476a-914a-100bdf16312f/tca14256-toc-0001-m.jpg)
Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy - Banna - 2022 -
![The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases | Scientific Reports The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-67676-1/MediaObjects/41598_2020_67676_Fig2_HTML.png)
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases | Scientific Reports
![Nuovo assetto organizzativo per l'area clinico – assistenziale e di ricerca di Gemelli Molise – Gemelli Molise Nuovo assetto organizzativo per l'area clinico – assistenziale e di ricerca di Gemelli Molise – Gemelli Molise](https://www.gemellimolise.it/wp-content/uploads/2020/07/05-848x267.jpg?x11888)
Nuovo assetto organizzativo per l'area clinico – assistenziale e di ricerca di Gemelli Molise – Gemelli Molise
![Frontiers | The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the Literature Frontiers | The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the Literature](https://www.frontiersin.org/files/Articles/651723/fonc-11-651723-HTML/image_m/fonc-11-651723-g001.jpg)
Frontiers | The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the Literature
![High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status | Journal of Hematology & Oncology | Full Text High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-022-01226-2/MediaObjects/13045_2022_1226_Fig1_HTML.png)